Victory Capital Management Inc. Buys 45,126 Shares of Ventas, Inc. $VTR

Victory Capital Management Inc. boosted its stake in Ventas, Inc. (NYSE:VTR) by 13.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 376,402 shares of the real estate investment trust’s stock after buying an additional 45,126 shares during the quarter. Victory Capital Management Inc. owned approximately 0.08% of Ventas worth $26,344,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Focus Partners Advisor Solutions LLC lifted its holdings in shares of Ventas by 182.3% during the third quarter. Focus Partners Advisor Solutions LLC now owns 23,650 shares of the real estate investment trust’s stock valued at $1,782,000 after acquiring an additional 15,273 shares during the period. Family Wealth Partners LLC increased its position in shares of Ventas by 68.6% during the 3rd quarter. Family Wealth Partners LLC now owns 7,711 shares of the real estate investment trust’s stock worth $540,000 after purchasing an additional 3,138 shares in the last quarter. Elo Mutual Pension Insurance Co increased its position in shares of Ventas by 26.2% during the 3rd quarter. Elo Mutual Pension Insurance Co now owns 52,589 shares of the real estate investment trust’s stock worth $3,681,000 after purchasing an additional 10,916 shares in the last quarter. Journey Strategic Wealth LLC bought a new position in Ventas during the 3rd quarter valued at about $327,000. Finally, APG Asset Management N.V. raised its stake in shares of Ventas by 4.5% in the third quarter. APG Asset Management N.V. now owns 254,100 shares of the real estate investment trust’s stock valued at $17,784,000 after acquiring an additional 11,000 shares during the last quarter. 94.18% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CFO Robert F. Probst sold 29,930 shares of the company’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $77.25, for a total value of $2,312,092.50. Following the completion of the transaction, the chief financial officer directly owned 138,434 shares of the company’s stock, valued at approximately $10,694,026.50. This represents a 17.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the transaction, the executive vice president owned 72,755 shares of the company’s stock, valued at approximately $6,184,175. This trade represents a 32.81% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 86,106 shares of company stock valued at $6,931,397. Company insiders own 1.00% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on VTR. Citigroup lifted their price target on Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a report on Wednesday, February 11th. Morgan Stanley set a $90.00 target price on Ventas in a research note on Friday, February 13th. The Goldman Sachs Group restated a “buy” rating and set a $100.00 target price on shares of Ventas in a research report on Monday, February 9th. Jefferies Financial Group reiterated a “buy” rating and issued a $93.00 price target on shares of Ventas in a report on Monday, December 15th. Finally, Royal Bank Of Canada lifted their price objective on Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 10th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Ventas currently has a consensus rating of “Moderate Buy” and an average target price of $89.00.

Ventas Stock Up 1.6%

Ventas stock opened at $86.22 on Tuesday. Ventas, Inc. has a fifty-two week low of $60.15 and a fifty-two week high of $87.87. The firm has a market capitalization of $40.95 billion, a price-to-earnings ratio of 159.66, a PEG ratio of 2.07 and a beta of 0.73. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67. The company’s 50 day simple moving average is $80.79 and its 200 day simple moving average is $75.93.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business had revenue of ($1,229.71) million for the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the business posted $0.81 EPS. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, sell-side analysts anticipate that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be given a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.08 annualized dividend and a yield of 2.4%. This is an increase from Ventas’s previous quarterly dividend of $0.48. Ventas’s payout ratio is presently 355.56%.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.